Tiziana Life Sciences (TLSA) Assets Average (2018 - 2025)

Tiziana Life Sciences (TLSA) has reported Assets Average for 8 consecutive years, with $14.0 million the latest figure, recorded in Q4 2025.

• Quarterly Assets Average rose 26.27% year-over-year to $14.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.0 million (up 26.27% YoY) and the FY2025 annual result came in at $11.4 million, down 2.94% from the prior year.
• Assets Average grew to $14.0 million in Q4 2025 per TLSA's latest filing, from $13.9 million in the prior quarter.
• Over the last five years, Assets Average for TLSA reached as high as $63.1 million in Q2 2021 and fell as low as $11.1 million in Q4 2024.
• A 5-year average of $27.7 million and a median of $18.4 million in 2023 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2021 — Assets Average surged 722.16% — and 2023, when it slumped 51.95%.
• Year by year, Assets Average stood at $53.3 million in 2021, then plunged by 42.26% to $30.8 million in 2022, then plunged by 51.95% to $14.8 million in 2023, then dropped by 24.84% to $11.1 million in 2024, then climbed by 26.27% to $14.0 million in 2025.
• According to Business Quant data, Assets Average over the past three periods registered $14.0 million, $13.9 million, and $11.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.